Content Marketing
Artificial Intelligence Designs Anti-Cancer Molecules Targeting CDK9
AI designs candidate drugs that bind and inhibit CDK9 by training machine learning models on biological and clinical data, then running virtual simulations to predict molecular interactions and efficacy. Reported examples include an AI-designed molecule with 30% higher efficacy against CDK9 and another that reduced tumor size in preclinical trials.
January 13, 20265 min read
Read More →